Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 50 for “"Antifolates"”.
-
Lipophilic Antifolates as Potential Antipsoriatic Agents
The lipophilic dihydrofolate reductase (DHFR) inhibitor m-azidopyrimethamine (MZP) was investigated for suitability for development as a topical antipsoriatic agent. The clinical features and treatments for psoriasis were reviewed. High performance liquid chromatography (HPLC) was employed as the …
-
The design of novel antifolates against pneumocystis carinii
… the partial success of the aforementioned antifolates, and also trimetrexate used alone, does suggest dihydrofolate reductase (DHFR) as a target for the development of antipneumocystis agents. From the DHFR inhibitory activities of 3'-substituted pyrimethamine analogues it was suggested …
-
DESIGN, SYNTHESIS, AND CHARACTERIZATION OF MULTI-TARGETING PYRROLOPYRIMIDINE ANTIFOLATES AS POTENTIAL SINGLE AGENT CHEMOTHERAPEUTIC ENTITIES
In cancer chemotherapy, the currently marketed antifolates have two major disadvantages: dose-limiting toxicities to normal tissues and susceptibility to drug resistance. These are due to their major transport by the ubiquitously expressed transporter and mutagenesis in enzymes present in cancer …
-
Synthesis of Novel 6-Substituted and 5-Substituted Pyrrolo[2,3-D] Pyrimidine Antifolates as Targeted Anticancer Therapies
… and current research progress in the areas of antifolates and chemotherapy of anticancer. The design and synthesis of classical 6- substituted pyrrolo[2,3-d]pyrimidines and 5-substituted pyrrolo[2,3-d]pyrimidines as potential antifolates have been described. The design variations include: …
-
Synthesis of novel 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as selective and potent anti-tumor agents
… (RTX): are a few examples of classical antifolates that are currently in clinical use. Although these compounds are widely used, all of them show dose limiting toxicity due to their non-specific transport into normal cells as well as malignant cells. Currently, clinically used classical …
-
Synthesis of 2,4,6-Substituted Pyrrolo[2,3-d]pyrimidines as Potential Anticancer Agents
… and work have been done in the areas of antifolates development, such as folate function, its three uptake mechanisms inside human cells, antifolates’ role in chemotherapy, <em>et. al</em>. In addition, the Structure-Activity-Relationship design rationale for the series of antifolates …
-
The proton-coupled folate transporter: biology and therapeutic applications to cancer
… pathways has been achieved through the use of antifolates. Unfortunately, the efficacy of many clinically approved antifolates is limited by a lack of tumor selectivity. Facilitative transport of folates into mammalian cells is achieved by the reduced folate carrier (RFC) and proton-coupled …
-
Classical Antifolates: Synthesis of 5-Substituted, 6-Substituted and 7-Substituted Pyrrolo[2,3-d]Pyrimidines as Targeted Anticancer Therapies
… research progress in the area of classical antifolates as the targeted anticancer therapies. In this study, twelve series of classical 5-, 6- and 7-substituted pyrrolo[2, 3-d]pyrimidines were designed and synthesized. Extensive structure modifications of the pyrrolo[2, 3-d] pyrimidine …
-
Folate transport and drug resistance in the African Trypanosome
… of these substrates was inhibited by classical antifolates, but not by non-classical antifolates. Genome-wide RNAi library screens with methotrexate and raltitrexed identified the putative folate transporter genes to be involved in drug resistance. RNAi knockdown of the folate transport genes …
-
Classical and Nonclassical Antifolates: Synthesis of Furo-[2,3-d] Pyrimidines Pyrrolo[2,3-d]Pyrimidines and Pyrimido-[4, 5-b]-Indoles
… and our research progress in the areas of antifolates. The design and synthesis of both classical and nonclassical bicyclic furo[2,3-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and tricyclic pyrimido[4,5-b]indoles as potential antifolates have been described. As a part of this study, a total …
-
Studies of N⁵, N¹⁰-methylene tetrahydrofolate reductase from porcine kidney and mouse L1210-induced tumor tissues, purification and interaction with antifolates
Methylene tetrahydrofolate reductase has been purified 1000-fold from porcine kidney and 400-fold from mouse L1210-induced tumor tissue by classical methods. The enzyme preparations have been demonstrated to be essentially free of contaminating methionine synthetase and serine transhydroxymethylase …
-
The Effects of ɤ-Glutamyl Hydrolase Modulation on Cancer Treatment and DNA Methylation in Human Cancer Cells
Folate and antifolates are retained in cells by polyglutamylation mediated by folylpolyglutamate synthase (FPGS), and are exported from cells after hydrolysis to monoglutamates by γ-glutamyl hydrolase (GGH). Polyglutamylated (anti)folates are retained in cells longer and are better substrates than …
-
Structural studies on antifolate drugs
… compounds fall into two categories :- Protonated antifolates with anions Substituted antifolates. The first category has been complemented with molecular orbital calculations on protonated and unprotonated :- 2-amino-4-oxo-pyrimidines (2-aminopyrimidin-4-ones) 2,4 diaminopyrimidines triazines. …
-
Structural Characterization And Therapeutic Utility Of The Proton-Coupled Folate Transporter
… as cancer therapeutics, although these classical antifolates display numerous off-target effects due to transport by the ubiquitous reduced folate carrier (RFC). In this dissertation, we determine the roles of multiple PCFT structure/function domains, and develop PCFT-specific antifolates to …
-
Synthesis of Bicyclic Thieno[2,3-d]Pyrimidines, Tricyclic Thieno[2,3-d]Pyrimidines and Thieno[3,2-d]Pyrimidines as Classical and Nonclassical Antifolates
… background and research progress in the areas of antifolates and antimitotic agents has been reviewed and discussed. Thymidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFTase) are important folate dependent enzymes that are targets for …
-
Pyrrolo[2,3-d]pyrimidine Classical Antifolates for Targeted Cancer Chemotherapy- Applications of Bioisosteric and Regioisomeric Substitutions for Improved Tumor-Selectivity and Potency
… the development of resistance. Clinically used antifolates methotrexate (MTX; DHFR inhibitor), pemetrexed (PMX; TS and GARFTase inhibitor), pralatrexate (PTX; DHFR inhibitor), and raltitrexed (RTX; TS inhibitor), have two major disadvantages: (1) dose-limiting toxicities due to ubiquitous …
-
The Therapeutic Targeting Of Folate Receptor Alpha Positive Tumors Via Folate Receptor Selective Novel 5- And 6- Substituted Pyrrolo [2,3-D]pyrimidine Antifolates"
… most treatments fail. The clinically approved antifolates, MTX and PMX, have greatly improved treatment outcomes in a number of malignancies, however they have been implicated in dose-limiting toxicities that are thought to arise from uptake mediated by the ubiquitously express protein, the …
-
TARGETING CANCER- ONE CARBON AT A TIME: DESIGN AND SYNTHESIS OF PYRIMIDINE BASED HETEROCYCLES AS POTENTIAL CANCER CHEMOTHERAPEUTICS
… and biological evaluation of pyrimidine-based antifolates as tumor selective, cytosolic and mitochondrial multitargeted one-carbon metabolism inhibitors for tumor therapy. The goal is to attain a single tumor selective chemotherapeutic, preclinical, antifolate, with effectiveness both in early …
Page 1 of 3